Trade 180 Life Sciences Corp. - ATNF CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.13 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.93 |
| Open | 2.05 |
| 1-Year Change | 97.12% |
| Day's Range | 2.05 - 2.13 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| May 6, 2024 | 1.93 | 0.00 | 0.00% | 1.93 | 1.93 | 1.93 |
| May 3, 2024 | 1.93 | 0.05 | 2.66% | 1.88 | 1.93 | 1.88 |
| May 2, 2024 | 1.93 | 0.02 | 1.05% | 1.91 | 1.93 | 1.91 |
| May 1, 2024 | 2.03 | 0.00 | 0.00% | 2.03 | 2.03 | 2.03 |
| Apr 30, 2024 | 2.10 | 0.24 | 12.90% | 1.86 | 2.10 | 1.86 |
| Apr 29, 2024 | 1.85 | -0.01 | -0.54% | 1.86 | 1.86 | 1.85 |
| Apr 26, 2024 | 1.78 | 0.03 | 1.71% | 1.75 | 1.78 | 1.75 |
| Apr 25, 2024 | 1.65 | -0.06 | -3.51% | 1.71 | 1.71 | 1.65 |
| Apr 24, 2024 | 1.68 | -0.17 | -9.19% | 1.85 | 1.85 | 1.68 |
| Apr 23, 2024 | 1.91 | 0.00 | 0.00% | 1.91 | 1.91 | 1.91 |
| Apr 22, 2024 | 1.79 | 0.02 | 1.13% | 1.77 | 1.79 | 1.76 |
| Apr 19, 2024 | 1.77 | -0.04 | -2.21% | 1.81 | 1.81 | 1.77 |
| Apr 18, 2024 | 1.85 | 0.02 | 1.09% | 1.83 | 1.90 | 1.83 |
| Apr 17, 2024 | 1.81 | 0.00 | 0.00% | 1.81 | 1.90 | 1.61 |
| Apr 16, 2024 | 1.45 | -0.32 | -18.08% | 1.77 | 2.13 | 1.45 |
| Apr 15, 2024 | 1.99 | -0.11 | -5.24% | 2.10 | 2.10 | 1.99 |
| Apr 12, 2024 | 2.16 | 0.02 | 0.93% | 2.14 | 2.16 | 2.07 |
| Apr 11, 2024 | 2.20 | -0.09 | -3.93% | 2.29 | 2.39 | 2.20 |
| Apr 10, 2024 | 2.34 | 0.08 | 3.54% | 2.26 | 2.39 | 2.26 |
| Apr 9, 2024 | 2.30 | 0.09 | 4.07% | 2.21 | 2.43 | 2.18 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
180 Life Sciences Corp. Company profile
About 180 Life Sciences Corp
180 Life Sciences Corp. is a clinical stage biotechnology company. The Company is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and inflammatory diseases. The Company has three product development platforms each of which focused on different diseases, pains or medical conditions and target different factors, molecules or proteins, and has their own product candidates, including Anti-TNF, which focusing on fibrosis and anti-tumour necrosis factor (anti-TNF); SCAs focused on drugs, which are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs); and α7nAChR focusing on alpha 7 nicotinic acetylcholine receptor (α7nAChR). It conducting clinical trials only for certain indications under the anti-TNF platform. Out of its three product development platforms, only the SCAs platform, involves products that are related to CBD.
Financial summary
BRIEF: For the nine months ended 30 September 2021, 180 Life Sciences Corp revenues was not reported. Net loss increased from $9M to $21.4M. Higher net loss reflects General and administrative increase of 58% to $8.7M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$1.90 to -$0.77.
| Industry: | Bio Therapeutic Drugs |
3000 El Camino Real
Bldg 4, Ste 200
94306
News
Bank of England preview: possible rate cut in summer?
The Bank of England (BoE) is widely expected to keep interest rates unchanged when it meets later this week. Data from Reuters shows a 90% chance of no change to the current rate of 5.25%, but the central bank will need to decide whether to change the messaging about rate cuts this year as traders will be paying close attention to any rate-cut clues.
12:39, 8 May 2024
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com